Clinical manifestations and long-term prognosis of Good syndrome: Results from a single-center cohort study from China

References

• Good RA. Agammaglobulinemia-a provocative experiment of nature. Bull University Minn Hosp Minn Med Fdn. 1954;26:1–19.
   Google Scholar
• Khawaja MR, Nelson Jr. RP, Miller N, Badve SS, Loehrer E, Czader M, et al. Immune-mediated diseases and immunodeficiencies associated with thymic epithelial neoplasms. J Clin Immunol. 2012;32(3):430–7.
   PubMed Web of Science ®Google Scholar
• Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86(1):31–42.
   PubMedGoogle Scholar
• Kelleher P, Misbah SA. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol. 2003;56(1):12–6.
   PubMed Web of Science ®Google Scholar
• Malphettes M, Gerard L, Galicier L, Boutboul D, Asli B, Szalat R, et al. Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications. Clin Infect Dis. 2015;61(2):e13-9–19.
   PubMed Web of Science ®Google Scholar
• Good RA, Varco RL. A clinical and experimental study of agammaglobulinemia. J Lancet. 1955;75(6):245–71.
   PubMedGoogle Scholar
• Del Pino Molina L, Wentink M, van Deuren M, van Hagen PM, Smith CIE, van der Burg M. Precursor B-cell development in bone marrow of Good syndrome patients. Clin Immunol. 2019;200:39–42.
   PubMed Web of Science ®Google Scholar
• Martinez B, Browne SK. Good syndrome, bad problem. Front Oncol. 2014;4:307.
   PubMedGoogle Scholar
• Kelesidis T, Yang O. Good's syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol. 2010;135(3):347–63.
   PubMed Web of Science ®Google Scholar
• Zaman M, Huissoon A, Buckland M, Patel S, Alachkar H, Edgar JD, et al. Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia). Clin Exp Immunol. 2019;195(1):132–8.
   PubMed Web of Science ®Google Scholar
• Dong JP, Gao W, Teng GG, Tian Y, Wang HH. Characteristics of Good's Syndrome in China: a systematic review. Chin Med J. 2017;130(13):1604–9.
   PubMed Web of Science ®Google Scholar
• Jansen A, van Deuren M, Miller J, Litzman J, de Gracia J, Saenz-Cuesta M, et al. Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective. Clin Immunol. 2016;171:12–7.
   PubMed Web of Science ®Google Scholar
• Multani A, Gomez CA, Montoya JG. Prevention of infectious diseases in patients with Good syndrome. Curr Opin Infect Dis. 2018;31(4):267–77.
   PubMed Web of Science ®Google Scholar
• Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, et al. The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J Thorac Oncol. 2015;10(10):1383–95.
   PubMed Web of Science ®Google Scholar
• Tarr PE, Sneller MC, Mechanic LJ, Economides A, Eger CM, Strober W, et al. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine. 2001;80(2):123–33.
   PubMed Web of Science ®Google Scholar
• Wang CH, Chan ED, Perng CL, Chian CF, Chen CW, Perng WC, et al. Intravenous immunoglobulin replacement therapy to prevent pulmonary infection in a patient with Good's syndrome. J Microbiol Immunol Infect. 2015;48(2):229–32.
   PubMedGoogle Scholar
• Micol R, Kayal S, Mahlaoui N, Beaute J, Brosselin P, Dudoit Y, et al. Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia. J Allergy Clin Immunol. 2012;129(3):770–7.
   PubMed Web of Science ®Google Scholar
• Bernard C, Frih H, Pasquet F, Kerever S, Jamilloux Y, Tronc F, et al. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 2016;15(1):82–92.
   PubMed Web of Science ®Google Scholar
• Sordet C, Cantagrel A, Schaeverbeke T, Sibilia J. Bone and joint disease associated with primary immune deficiencies. Joint Bone Spine. 2005;72(6):503–14.
   PubMed Web of Science ®Google Scholar
• Rivoisy C, Besse B, Girard N, Lioger B, Viallard JF, Lega JC, et al. Thymic epithelial tumor-associated cytopenia: a 10-year observational study in France. J Thorac Oncol. 2016;11(3):391–9.
   PubMed Web of Science ®Google Scholar
• Antar AI, Otrock ZK, Kharfan-Dabaja MA, Mahfouz RA, Alameddine RS, El-Majzoub NM, et al. Thymoma with concomitant pure red cell aplasia, good's syndrome and myasthenia gravis responding to rituximab. Indian J Hematol Blood Transfus. 2016;32(Suppl 1):219–22.
   PubMedGoogle Scholar
• Liu Y, Xu Y, Tian X, Huang H, Hou X, Chen M, et al. Thymic neoplasms patients complicated with bronchiectasis: case series in a Chinese hospital and literature review. Thorac Cancer. 2019;10(4):791–8.
   PubMed Web of Science ®Google Scholar
• Liu K, Cowlishaw JL. Beware of the patient with thymectomy: Good's syndrome in a patient presenting with diarrhea. ACG Case Rep J. 2013;1:33–5.
   PubMedGoogle Scholar
• Kirk BW, Freedman SO. Hypogammaglobulinemia, thymoma and ulcerative colitis. Can Med Assoc J. 1967;96(18):1272–7.
   PubMed Web of Science ®Google Scholar
• Jagessar SAR, Long C, Cui B, Zhang F. Improvement of Good's syndrome by fecal microbiota transplantation: the first case report. J Int Med Res. 2019;47(7):3408–15.
   PubMed Web of Science ®Google Scholar
• Masci AM, Palmieri G, Vitiello L, Montella L, Perna F, Orlandi P, et al. Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia. Blood. 2003;101(8):3106–8.
   PubMed Web of Science ®Google Scholar
• Lougaris V, Vitali M, Baronio M, Tampella G, Plebani A. BAFF-R mutations in Good's syndrome. Clin Immunol. 2014;153(1):91–3.
   PubMed Web of Science ®Google Scholar
• Berard M, Tough DF. Qualitative differences between naïve and memory T cells. Immunology. 2002;106(2):127–38.
   PubMed Web of Science ®Google Scholar
• Gonzalez SM, Taborda NA, Rugeles MT. Role of different subpopulations of CD8+ T cells during HIV exposure and infection. Front Immunol. 2017;8:936.
   PubMed Web of Science ®Google Scholar
• Burbelo PD, Browne SK, Sampaio EP, Giaccone G, Zaman R, Kristosturyan E, et al. Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood. 2010;116(23):4848–58.
   PubMed Web of Science ®Google Scholar
• Marx A, Hohenberger P, Hoffmann H, Pfannschmidt J, Schnabel P, Hofmann HS, et al. The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond. J Thorac Oncol. 2010;5(10):S266–S72.
   PubMedGoogle Scholar
• Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S, ESMO Guidelines Committee. Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 (Suppl 5):v40–55.
   PubMed Web of Science ®Google Scholar
• Thongngarm T, Boonyasiri A, Pradubpongsa P, Tesavibul N, Anekpuritanang T, Kreetapirom P, et al. Features and outcomes of immunoglobulin therapy in patients with Good syndrome at Thailand's largest tertiary referral hospital. Asian Pac J Allergy Immunol. 2019;37:109–15.
   PubMed Web of Science ®Google Scholar